BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
BIOA on Nasdaq
Shares outstanding
35,863,005
Price per share
$18.27
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
23,526,757
Total reported value
$312,321,217
% of total 13F portfolios
0%
Share change
+1,599,465
Value change
+$36,760,929
Number of holders
111
Price from insider filings
$18.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fortney Kristen 7.2% $48,279,538 2,704,736 Kristen Fortney 31 Dec 2025
Cormorant Asset Management, LP 5.7% -4.7% $36,424,799 -$1,785,000 2,040,605 -4.7% Cormorant Asset Management, LP 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P. 3.7% $5,740,380 1,310,589 RA Capital Management, L.P. 31 Dec 2024
ADAR1 Capital Management, LLC 0.4% -100% $2,419,746 -$32,157,900 135,560 -93% ADAR1 Capital Management, LLC 31 Dec 2025

As of 31 Dec 2025, 111 institutional investors reported holding 23,526,757 shares of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA). This represents 66% of the company’s total 35,863,005 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
a16z Capital Management, L.L.C. 9% 3,233,170 0% 2.8% $44,068,107
Sofinnova Investments, Inc. 6.4% 2,293,788 0% 1.3% $30,346,815
Cormorant Asset Management, LP 5.7% 2,040,605 -4.7% 1.5% $26,997,204
Octagon Capital Advisors LP 4.5% 1,598,000 2.6% $21,141,540
BlackRock, Inc. 4.3% 1,527,541 +19% 0% $20,209,367
VANGUARD GROUP INC 3.9% 1,414,770 -14% 0% $18,717,407
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.9% 1,050,000 0.02% $13,891,500
ORBIMED ADVISORS LLC 2.2% 790,901 0% 0.22% $10,463,620
Sands Capital Alternatives, LLC 2.2% 786,353 0% 2% $10,403,450
Pivotal bioVenture Partners Investment Advisor LLC 1.8% 653,374 0% 3.3% $8,644,138
GEODE CAPITAL MANAGEMENT, LLC 1.6% 591,377 +5.1% 0% $7,826,327
COSMIC MANAGEMENT, LLC 1.4% 501,833 0% 2% $6,639,251
STATE STREET CORP 1.2% 422,846 +113% 0% $5,594,253
JANUS HENDERSON GROUP PLC 1.1% 409,207 0% $5,405,624
REDPOINT MANAGEMENT, LLC 1.1% 383,254 0% 3.7% $5,070,450
D. E. Shaw & Co., Inc. 0.95% 339,909 +226% 0% $4,496,996
JACOBS LEVY EQUITY MANAGEMENT, INC 0.93% 334,126 +57% 0.02% $4,420,487
MORGAN STANLEY 0.87% 311,659 +37% 0% $4,123,249
ACADIAN ASSET MANAGEMENT LLC 0.78% 277,957 +2504% 0.01% $3,672,000
Comprehensive Financial Management LLC 0.76% 271,842 0% 0.11% $3,596,470
DIADEMA PARTNERS LP 0.76% 271,164 2.1% $3,587,500
SPHERA FUNDS MANAGEMENT LTD. 0.68% 243,035 0.67% $3,215,353
CITADEL ADVISORS LLC 0.64% 230,543 +102% 0% $3,050,084
Invesco Ltd. 0.64% 228,673 0% $3,025,344
MILLENNIUM MANAGEMENT LLC 0.64% 228,414 -25% 0% $3,021,917

Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 23,526,757 $312,321,217 +$36,760,929 $13.23 111
2025 Q3 21,259,082 $125,003,330 +$3,516,038 $5.88 92
2025 Q2 20,716,453 $85,559,282 +$3,327,577 $4.13 81
2025 Q1 20,278,591 $76,157,053 +$1,658,645 $3.76 65
2024 Q4 19,641,111 $113,720,000 -$68,696,192 $5.79 64
2024 Q3 20,709,688 $430,774,211 +$424,388,861 $20.80 58